Clinical Trials Browser

Phase 2 × NPI 2358 × Thoracic × Clear all

NCT05599789 2025-02-18

KeyPemls-004

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05745350 2025-02-11

First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Phase 2 Recruiting

Small Cell Lung Cancer Extensive Stage